Concepedia
Statistics
Publications
15
Citations
721
H-Index
14
Active since
1992
Affiliations
University of Tübingen(Current)
University Hospital Regensburg
Evotec (Germany)
University of Hohenheim
University Children's Hospital Tübingen
Timo Weiland is an author at University of Tübingen specializing in oncology, medicine, and pharmacology.
Publications per year
1992–2024
Resveratrol as a Pan-HDAC Inhibitor Alters the Acetylation Status of Jistone Proteins in Human-Derived Hepatoblastoma Cells
Sascha Venturelli, Alexander Berger, Alexander Böcker et al. · PLoS ONE · 2013 · 168 citations · Full text
Medicine, Oncology, Pharmacology +11
Kaempferol, a new nutrition-derived pan-inhibitor of human histone deacetylases
Alexander Berger, Sascha Venturelli, Mascha Kallnischkies et al. · The Journal of Nutritional Biochemistry · 2012 · 112 citations
Life Sciences, Biochemistry, Pharmacology +11
Differential Induction of Apoptosis and Senescence by the DNA Methyltransferase Inhibitors 5-Azacytidine and 5-Aza-2′-Deoxycytidine in Solid Tumor Cells
Sascha Venturelli, Alexander Berger, Timo Weiland et al. · Molecular Cancer Therapeutics · 2013 · 97 citations
Medicine, Oncology, Pharmacology +17
Innate Immune Defense Defines Susceptibility of Sarcoma Cells to Measles Vaccine Virus-Based Oncolysis
Susanne Berchtold, Johanna W. Lampe, Timo Weiland et al. · Journal of Virology · 2013 · 58 citations · Full text
Life Sciences, Immunology, Oncology +17
Enhanced killing of therapy‐induced senescent tumor cells by oncolytic measles vaccine viruses
Timo Weiland, Johanna W. Lampe, Sascha Venturelli et al. · International Journal of Cancer · 2013 · 54 citations · Full text
Medicine, Oncology, Pharmacology +16
1–5 of 15